Search

everythinglearnresearchcommunity

for

Search:↓

Digital health education may reduce stress, anxiety, and depression in PCOS patients.

Self-assessed hirsutism scores are not reliable for clinical diagnosis but may help in screening.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Hair loss patients may often have Body Dysmorphic Disorder, and proper psychological assessment and treatment can help.

Probiotics significantly reduce the severity of atopic dermatitis.

Depression may be linked to changes in body electrolytes and muscle inactivity, similar to effects of weightlessness.

Premature graying of hair significantly harms psychological and social wellbeing.

Future anxiety about male pattern baldness is linked to personality traits and social perceptions.

Atopic dermatitis significantly lowers the quality of life for infants and their families.

Marijuana use is linked to higher chances of needing treatment for urinary symptoms in men over 40.

People with telogen effluvium and scalp discomfort might have low vitamin B12 and could benefit from B12 supplements.

The SBN system effectively assesses alopecia areata severity and predicts its course.

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

The two-factor model fits better for Chinese patients' understanding of illness causes than the original four-factor model.

Hair loss severity is linked to depression, not anxiety, in Filipino men, with older, less educated men with more hair loss at higher risk.

Hair loss in South Saudi Arabia adults often harms quality of life and leads to depression.

Alopecia significantly impacts mental health and quality of life, requiring psychological support.

Hair loss lowers quality of life, causing embarrassment, frustration, and sexual rejection.

SII is a useful and affordable tool to assess and monitor alopecia areata.

Disease-specific tools better assess quality of life in alopecia areata patients.

Scalp photography helps patients feel less anxious about hair loss, agree more with doctors on severity, and stay motivated for treatment.

Negative illness perceptions increase emotional distress, worsening OCD symptoms in alopecia areata patients.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Finasteride may increase the risk of depression, anxiety, and suicidal thoughts.

Emotional symptoms from alopecia areata reduce work productivity and daily activity.

Changes in early neurosteroid levels can affect adult learning and anxiety.

Finasteride users with sexual issues often experience depression.

Alopecia areata patients have worse quality of life, anxiety, and depression than vitiligo patients.

Antidepressants may improve or resolve scalp dysesthesia in most patients.